RLI Corp (RLI) CEO Craig Kliethermes granted 15,000 stock options

Rhea-AI Filing Summary

RLI Corp's chief executive officer, Craig W. Kliethermes, received a new stock option award. On 02/02/2026, he was granted options to buy 15,000 shares of RLI common stock at an exercise price of $58.74 per share. The options were received at a price of $0 to him.

The options vest over time under a scheduled plan. Beginning one year after the grant date, 20% of the total options become exercisable each year, so the award vests in equal 20% increments over five years. The options are directly owned and are scheduled to expire on 02/03/2034.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kliethermes Craig W

Role CHIEF EXECUTIVE OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	15,000	$0.00	--

Holdings After Transaction: Stock Option — 15,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kliethermes Craig W

(Last) (First) (Middle)

9025 N. LINDBERGH DRIVE

(Street)

PEORIA IL 61615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RLI CORP [ RLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$58.74	02/02/2026		A		15,000		02/02/2027(1)	02/03/2034	Common Stock	15,000	$0	15,000	D

Explanation of Responses:

1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.

	/s/ Craig W. Kliethermes	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did RLI (RLI) CEO Craig Kliethermes receive in this Form 4 filing?

Craig Kliethermes received a stock option grant for 15,000 shares. The options allow him to buy RLI common stock at $58.74 per share. They cost him $0 upfront and vest gradually over five years under a defined vesting schedule.

What is the exercise price of the new RLI (RLI) stock options?

The exercise price of the options is $58.74 per share. This means Craig Kliethermes can buy up to 15,000 RLI common shares at $58.74, once vested. Any potential benefit depends on RLI’s future share price exceeding this level.

How do Craig Kliethermes’ RLI (RLI) options vest over time?

The options vest in 20% increments each year starting one year after grant. Beginning one year from the 02/02/2026 grant date, 20% of the total becomes exercisable annually, so the 15,000 options fully vest over five years according to the disclosed schedule.

When do the new RLI (RLI) CEO stock options expire?

The stock options held by Craig Kliethermes expire on 02/03/2034. He may exercise vested options any time between their vesting dates and this expiration date, subject to plan rules and any applicable company or regulatory trading restrictions.

How many RLI (RLI) derivative securities does the CEO own after this grant?

After the reported transaction, Craig Kliethermes beneficially owns 15,000 stock options. All these derivative securities are reported as directly owned. As they vest, each option represents the right to purchase one share of RLI common stock at $58.74.

Was this RLI (RLI) Form 4 transaction a purchase or a grant?

This transaction represents a grant of stock options, not an open-market purchase. The Form 4 shows transaction code “A” for acquisition, with a price of $0, indicating an award under a compensation plan rather than shares bought for cash in the market.